Menu
GWAS Study

Genes associated with anhedonia: a new analysis in a large clinical trial (GENDEP).

Ren H, Fabbri C, Uher R et al.

30104601 PubMed ID
GWAS Study Type
2110 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

RH
Ren H
FC
Fabbri C
UR
Uher R
RM
Rietschel M
MO
Mors O
HN
Henigsberg N
HJ
Hauser J
ZA
Zobel A
MW
Maier W
DM
Dernovsek MZ
SD
Souery D
CA
Cattaneo A
BG
Breen G
CI
Craig IW
FA
Farmer AE
MP
McGuffin P
LC
Lewis CM
AK
Aitchison KJ
Chapter II

Abstract

Summary of the research findings

A key feature of major depressive disorder (MDD) is anhedonia, which is a predictor of response to antidepressant treatment. In order to shed light on its genetic underpinnings, we conducted a genome-wide association study (GWAS) followed by investigation of biological pathway enrichment using an anhedonia dimension for 759 patients with MDD in the GENDEP study. The GWAS identified 18 SNPs associated at genome-wide significance with the top one being an intronic SNP (rs9392549) in PRPF4B (pre-mRNA processing factor 4B) located on chromosome 6 (P = 2.07 × 10-9) while gene-set enrichment analysis returned one gene ontology term, axon cargo transport (GO: 0008088) with a nominally significant P value (1.15 × 10-5). Furthermore, our exploratory analysis yielded some interesting, albeit not statistically significant genetic correlation with Parkinson's Disease and nucleus accumbens gray matter. In addition, polygenic risk scores (PRSs) generated from our association analysis were found to be able to predict treatment efficacy of the antidepressants in this study. In conclusion, we found some markers significantly associated with anhedonia, and some suggestive findings of related pathways and biological functions, which could be further investigated in other studies.

759 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

2110
Total Participants
GWAS
Study Type
Yes
Replicated
1,351 individuals
Replication Participants
European
Ancestry
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.